Bloom Energy vs. NuScale Power: Which Energy Innovator Stock Is a Better Buy in 2026?

The article frames Bloom Energy (BE) as the more investable 2026 option versus NuScale Power (SMR) by citing FY2025 revenue of $2B+ (+37%) and narrowing losses, against NuScale’s ~$31.5M revenue (-15%) and ~$356M net loss. It also highlights Bloom’s free cash flow of about $57.2M and forward P/E near 84x with P/S of 19.4x, while NuScale is described as pre-revenue with negative free cash flow of over $460M and a high P/S of 234x. Key risks include Bloom’s 2026 securities class action over alleged supply chain misrepresentations and NuScale’s lack of delivered modules and ongoing partner-related litigation.

Analysis

BE is starting to trade less like a “clean tech” name and more like a latency-sensitive infrastructure vendor for AI loads: the value is in turning power availability into revenue faster than grid interconnection can. That shifts the market from debating TAM to debating backlog conversion, gross margin durability, and whether partners can finance deployments without forcing BE to absorb working-capital strain. If the deployment cadence holds, the equity can rerate on operating leverage; if not, the multiple is vulnerable because leverage magnifies any execution miss.

SMR is the opposite: it is a long-duration call option on regulatory patience and capital availability, not a near-term earnings story. The key second-order risk is dilution/financing before commercialization, because every quarter without binding delivery contracts makes the implied terminal value more dependent on sentiment than fundamentals. In the next 1-3 months, litigation and partner credibility are the more relevant catalysts than the technology narrative; over 6-18 months, the market will care whether the company can convert certification into financed projects, or whether certified status remains a stranded asset.

The consensus is missing that this is not a “best tech wins” contest; it is a cash-conversion contest. BE’s advantage is timing: it can monetize AI power urgency now, while SMR’s moat may not matter until after the market has already discounted a much higher cost of capital. Contrarian risk: if datacenter demand softens or utility-scale power gets cheaper, BE’s growth premium compresses quickly; if SMR lands even one credible, funded deployment, the stock can squeeze hard because positioning is likely one-way.

Key Decisions for Investors

• Long BE / short SMR pair trade for the next 1-3 months: express the view that near-term monetizable power demand beats distant optionality; size modestly because SMR can squeeze on contract headlines.
• Add BE on pullbacks only, targeting entries after any post-headline fade; thesis breaks if FY26 revenue growth guide or gross margin expansion stalls, or if lawsuit/supply-chain disclosures hit backlog quality.
• Use SMR put spreads rather than outright short if borrow is tight: 3-6 month tenor to capture financing and litigation risk while limiting squeeze exposure; thesis fails on binding utility/DOE-backed deployment announcements.
• Watch AEP and BN as indirect winners from deployment-financing and infrastructure-partnership flow-through; if BE backlog accelerates, these names can benefit from capital allocation and project-finance upside without BE’s idiosyncratic execution risk.
• If BE re-rates sharply on AI datacenter headlines, trim into strength rather than chase: the stock’s rerating case is real, but valuation sensitivity is high if revenue growth normalizes faster than expected.